| Dr Byron D Danielson, MD | |
|
2101 Elm St N, Fargo, ND 58102-2417 | |
| (701) 239-3700 | |
| Not Available |
| Full Name | Dr Byron D Danielson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 2101 Elm St N, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144394388 | NPI | - | NPPES |
| 12375 | Medicaid | ND | |
| 2064787 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 3768 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Byron D Danielson, MD 2578 Willow Rd N, Fargo, ND 58102-2161 Ph: (701) 237-5525 | Dr Byron D Danielson, MD 2101 Elm St N, Fargo, ND 58102-2417 Ph: (701) 239-3700 |
News Archive
Healthy, full-term newborn babies tend to lose weight during the first few days after their birth. A groundbreaking new study published in the latest issue of the Journal of Human Lactation explores the reasons why certain newborns lose more (or less) than others and what conclusions can be drawn from the research.
Arrowhead Research Corporation today announced that it has executed an exclusive world-wide license on technology developed by Drs. Wadih Arap and Renata Pasqualini at MD Anderson Cancer Center for use in weight loss and obesity-related metabolic conditions, and that it has launched a new company, Ablaris Therapeutics Inc., to commercialize this platform.
Using human embryonic stem cells to create a type of cardiac cells known as sinotrial (SA) node pacemaker cells, a team of scientists from Israel and Canada have developed a biological pacemaker that overcomes many of the limitations of electrical pacemakers.
Thirty years after scientists coined the term "hygiene hypothesis" to suggest that increased exposure to microorganisms could benefit health, University of Colorado Boulder researchers have identified an anti-inflammatory fat in a soil-dwelling bacterium that may be responsible.
Wistar researchers have found that soluble antibodies promote tumor progression by inducing accumulation of myeloid-derived suppressor cells (MDSCs) in pre-clinical cancer models. Results were published online in Cancer Immunology Research.
› Verified 6 days ago
Dr. Keri Lynn Crewson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: Sanford Health, 801 Broadway North, Fargo, ND 58122 Phone: 701-234-5933 Fax: 701-234-7230 | |
Abdallah M Mansour, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8900 | |
Derek Anderson, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
Gerald G Gross, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 4th St N, Fargo, ND 58102 Phone: 701-234-6161 | |
Paul James Carson, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-4811 Fax: 701-234-6979 | |
Howard L Russell, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 820 N 4th St, Fargo, ND 58122 Phone: 701-234-6161 Fax: 701-234-3861 | |
Dr. Emuejevoke Joseph Okoh, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 |